282 related articles for article (PubMed ID: 37175680)
21. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
Yamada S; Asakura H
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
[TBL] [Abstract][Full Text] [Related]
22. Renal artery thrombosis in SARS-CoV-2 infection: a case report.
Huang H; Lin C; Chen Y; Wu X; Lin M; Chen S; Li K
BMC Nephrol; 2022 May; 23(1):175. PubMed ID: 35524226
[TBL] [Abstract][Full Text] [Related]
23. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
24. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and thrombosis: The role of hemodynamics.
Sastry S; Cuomo F; Muthusamy J
Thromb Res; 2022 Apr; 212():51-57. PubMed ID: 35219932
[TBL] [Abstract][Full Text] [Related]
26. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
Mei H; Luo L; Hu Y
J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
Haimei MA
Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 associated coagulopathy and thrombosis in cancer.
Levi M; van Es N
Thromb Res; 2022 May; 213 Suppl 1():S72-S76. PubMed ID: 36210564
[TBL] [Abstract][Full Text] [Related]
29. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
Petito E; Falcinelli E; Paliani U; Cesari E; Vaudo G; Sebastiano M; Cerotto V; Guglielmini G; Gori F; Malvestiti M; Becattini C; Paciullo F; De Robertis E; Bury L; Lazzarini T; Gresele P;
J Infect Dis; 2021 Mar; 223(6):933-944. PubMed ID: 33280009
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.
Kaur S; Singh A; Kaur J; Verma N; Pandey AK; Das S; Bhattacharyya S; Guchhait P
Blood Cells Mol Dis; 2022 May; 94():102653. PubMed ID: 35180460
[TBL] [Abstract][Full Text] [Related]
31. Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.
Yamamoto A; Wada H; Ichkawa Y; Tanaka M; Tashiro H; Shiraki K; Shimpo H; Yamashita Y; Mastumoto T; Shimaoka M; Iba T; Suzuki-Inoue K
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203210
[TBL] [Abstract][Full Text] [Related]
32. Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection.
Khryshchanovich VY; Rogovoy NA; Nelipovich EV
Am Surg; 2023 May; 89(5):2046-2048. PubMed ID: 34049454
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
34. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.
Yamamoto A; Wada H; Tomida M; Ichikawa Y; Ezaki M; Shiraki K; Shimaoka M; Iba T; Suzuki-Inoue K; Kawamura M; Shimpo H
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443690
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
Lim MS; Mcrae S
Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
[TBL] [Abstract][Full Text] [Related]
36. Multi-factorial Mechanism Behind COVID-19 Related Thrombosis.
Ali EW; Ibrahim IK
Med Arch; 2022 Feb; 76(1):62-65. PubMed ID: 35422572
[TBL] [Abstract][Full Text] [Related]
37. Thromboelastography findings in critically ill COVID-19 patients.
Salem N; Atallah B; El Nekidy WS; Sadik ZG; Park WM; Mallat J
J Thromb Thrombolysis; 2021 May; 51(4):961-965. PubMed ID: 33011896
[TBL] [Abstract][Full Text] [Related]
38. COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective.
John NA; John J; Kamble P; Singhal A; Daulatabad V; Vamshidhar IS
Horm Mol Biol Clin Investig; 2021 Nov; 43(1):89-96. PubMed ID: 34786893
[TBL] [Abstract][Full Text] [Related]
39. Coagulation Dysfunction.
Fei Y; Tang N; Liu H; Cao W
Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulant therapy in COVID-19: A narrative review.
Mohseni Afshar Z; Tavakoli Pirzaman A; Hosseinzadeh R; Babazadeh A; Taghizadeh Moghadam MA; Miri SR; Sio TT; Sullman MJM; Barary M; Ebrahimpour S
Clin Transl Sci; 2023 Sep; 16(9):1510-1525. PubMed ID: 37326220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
